The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
Published in Focus on Patient Care
Individuals with dry eye have hope as researchers continue to learn more about causes, symptoms and treatments.
UAB has implemented a new application suite to improve clinical trial management, and enhance communication among trial sites and with study participants.
Researchers have found that an interaction between a mutant gene and alpha synuclein in neurons leads to hallmark pathologies seen in Parkinson’s disease, findings that may lead to new mechanisms and targets for neuroprotection.
The zebrafish is making its mark in the field of biomedical research, becoming one of the fastest-growing models of human disease.
The ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.
BCRFA is accepting proposals for a two-year collaborative breast cancer research award among the UAB Cancer Center, Southern Research and HudsonAlpha.
Published in Focus on Patient Care
A potent compound discovered by UAB researchers in Antarctic waters could be a new weapon against a bacterial infection that kills thousands each year.
AIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.
UAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
A treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
The facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.
UAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.
UAB researchers uncover new information about drivers’ likelihood to participate in risky roadway behavior.
Nathaniel Lawson, DMD, assistant professor at the University of Alabama Birmingham School of Dentistry, is the recipient of the 2015 John W. Stanford New Investigator Award given by the American Dental Association.
Published in Faculty Excellence
Gift from United Therapeutics will establish Xenotransplantation Institute and bring additional resources to support the endeavor with a goal of genetically modified kidney transplants taking place by 2021.
Published in Faculty Excellence
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
Page 1 of 62

News You Can Use

 
Back to Top